The aim of this study was to establish the contribution of insulin resistance to the morning (A.M.) versus afternoon (P.M.) lower glucose tolerance of people with type 2 diabetes (T2D). Eleven subjects with T2D (mean [SD] diabetes duration 0.79 [0.23] years, BMI 28.3 [1.8] kg/m2, A1C 6.6% [0.26%] [48.9 (2.9) mmol/mol]), treatment lifestyle modification only) and 11matched control subjects without diabetes were monitored between 5:00 and 8:00 A.M. and P.M. (in random order) on one occasion (study 1), and on a subsequent occasion, they underwent an isoglycemic clamp (A.M. and P.M., both between 5:00 and 8:00, insulin infusion rate 10 mU/m2/min) (study 2). In study 1, plasma glucose, insulin, C-peptide, and glucagon were higher and insulin clearance lower in subjects with T2D A.M. versus P.M. and versus control subjects (P < 0.05), whereas free fatty acid, glycerol, and b-hydroxybutyrate were lower A.M. versus P.M. However, in study 2 at identical hyperinsulinemia A.M. and P.M. (~150 pmol/L), glucose Ra and glycerol Ra were both less suppressed A.M. versus P.M. (P < 0.05) in subjects with T2D. In contrast, in control subjects, glucose Ra was more suppressed A.M. versus P.M. Leucine turnover was no different A.M. versus P.M. In conclusion, in subjects with T2D, insulin sensitivity for glucose (liver) and lipid metabolism has diurnal cycles (nadir A.M.) opposite that of control subjects without diabetes already at an early stage, suggesting a marker of T2D

Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation from Physiology at an Early Stage

Tura A.;
2023

Abstract

The aim of this study was to establish the contribution of insulin resistance to the morning (A.M.) versus afternoon (P.M.) lower glucose tolerance of people with type 2 diabetes (T2D). Eleven subjects with T2D (mean [SD] diabetes duration 0.79 [0.23] years, BMI 28.3 [1.8] kg/m2, A1C 6.6% [0.26%] [48.9 (2.9) mmol/mol]), treatment lifestyle modification only) and 11matched control subjects without diabetes were monitored between 5:00 and 8:00 A.M. and P.M. (in random order) on one occasion (study 1), and on a subsequent occasion, they underwent an isoglycemic clamp (A.M. and P.M., both between 5:00 and 8:00, insulin infusion rate 10 mU/m2/min) (study 2). In study 1, plasma glucose, insulin, C-peptide, and glucagon were higher and insulin clearance lower in subjects with T2D A.M. versus P.M. and versus control subjects (P < 0.05), whereas free fatty acid, glycerol, and b-hydroxybutyrate were lower A.M. versus P.M. However, in study 2 at identical hyperinsulinemia A.M. and P.M. (~150 pmol/L), glucose Ra and glycerol Ra were both less suppressed A.M. versus P.M. (P < 0.05) in subjects with T2D. In contrast, in control subjects, glucose Ra was more suppressed A.M. versus P.M. Leucine turnover was no different A.M. versus P.M. In conclusion, in subjects with T2D, insulin sensitivity for glucose (liver) and lipid metabolism has diurnal cycles (nadir A.M.) opposite that of control subjects without diabetes already at an early stage, suggesting a marker of T2D
2023
Istituto di Neuroscienze - IN - Sede Secondaria Padova
FATTY-ACID-METABOLISM, DOSE-RESPONSE CHARACTERISTICS, DAWN PHENOMENON, GLUCOSE-TOLERANCE, GROWTH-HORMONE, PLASMA-INSULIN, SUPPRESSION, SECRETION, COUNTER, REGULATION, MECHANISMS
File in questo prodotto:
File Dimensione Formato  
db220721.pdf

Open Access dal 14/07/2024

Tipologia: Versione Editoriale (PDF)
Licenza: Altro tipo di licenza
Dimensione 2.96 MB
Formato Adobe PDF
2.96 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/523668
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact